A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy
Clinical trial NCT00468546 · COMPLETED
Trial details
- NCT number
- NCT00468546
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2005-01-01
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.